ICL Reports Second Quarter 2026 Results
Bullish over 6–12 months as Elevate savings and the new division structure lift margins and cash flow.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish over 6–12 months as Elevate savings and the new division structure lift margins and cash flow.
What happened and why it matters
ICL posted Q2 2026 sales of $2.135B, up 17% YoY, with operating income of $266M and adjusted EBITDA of $448M. The company reaffirmed 2026 EBITDA guidance and unveiled Elevate, a cost-saving program targeting over $350M in annualized savings by 2028, while reorganizing into three end-market divisions to sharpen growth focus.
Stronger-than-expected quarterly results, reaffirmed guidance, and a concrete cost-reduction program imply higher margins and cash flow, potentially driving multiple expansion.
Q2 2026 sales $2.135B, up 17% YoY.
Operating income $266M; adjusted $281M; adjusted net income $149M.
Elevate cost savings target: $350M annualized by 2028; savings begin 2027.
New structure: Nutrition Solutions, Industrial Products, Growing Solutions; Essential Minerals.
Dividend 5.81¢/share; potash price $376/ton and 1,081k MT volume.
Category: Earnings. The release combines quarterly results, segmentation, and strategic restructuring, shaping near-term earnings trajectory and valuation.
More AI-analyzed coverage connected to this story